580 related articles for article (PubMed ID: 28254221)
21. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age.
Liao CC; Lee RK; Lin SY; Lin MH; Hwu YM
Taiwan J Obstet Gynecol; 2016 Apr; 55(2):239-43. PubMed ID: 27125408
[TBL] [Abstract][Full Text] [Related]
22. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
[TBL] [Abstract][Full Text] [Related]
23. Factors associated with extremely high progesterone concentrations on the day of HCG administration.
Tsai YR; Lin YJ; Lin YC; Hsu TY; Lan KC
J Gynecol Obstet Hum Reprod; 2020 Oct; 49(8):101720. PubMed ID: 32113001
[TBL] [Abstract][Full Text] [Related]
24. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles.
Kuang Y; Hong Q; Chen Q; Lyu Q; Ai A; Fu Y; Shoham Z
Fertil Steril; 2014 Jan; 101(1):105-11. PubMed ID: 24161646
[TBL] [Abstract][Full Text] [Related]
25. Oral oestradiol supplementation as luteal support in IVF/ICSI cycles: a prospective, randomized controlled study.
Lin H; Li Y; Li L; Wang W; Zhang Q; Chen X; Yang D
Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):171-5. PubMed ID: 23287635
[TBL] [Abstract][Full Text] [Related]
26. Premature luteinization defined as progesterone estradiol ratio >1 on hCG administration day seems to adversely affect clinical outcome in long gonadotropin-releasing hormone agonist cycles.
Ozçakir HT; Levi R; Tavmergen E; Göker EN
J Obstet Gynaecol Res; 2004 Apr; 30(2):100-4. PubMed ID: 15009611
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
[TBL] [Abstract][Full Text] [Related]
28. Reproducibility and clinical significance of pre-ovulatory serum progesterone level and progesterone/estradiol ratio on the day of human chorionic gonadotropin administration in infertile women undergoing repeated in vitro fertilization cycles.
Lin YJ; Lan KC; Huang FJ; Lin PY; Chiang HJ; Kung FT
Reprod Biol Endocrinol; 2015 May; 13():41. PubMed ID: 25967104
[TBL] [Abstract][Full Text] [Related]
29. The value of the progesterone-to-estradiol ratio on the day of hCG administration in predicting ongoing pregnancy and live birth rates in normoresponders undergoing GnRH antagonist cycles.
Cetinkaya ES; Berker B; Aytac R; Atabekoglu C; Sonmezer M; Ozmen B
Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):452-7. PubMed ID: 23932375
[TBL] [Abstract][Full Text] [Related]
30. A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in vitro fertilization cycles.
Kondapalli LA; Molinaro TA; Sammel MD; Dokras A
Hum Reprod; 2012 Sep; 27(9):2690-7. PubMed ID: 22752608
[TBL] [Abstract][Full Text] [Related]
31. Effect of elevated estradiol levels on the hCG administration day on IVF pregnancy and birth outcomes in the long GnRH-agonist protocol: analysis of 3393 cycles.
Wang M; Hao C; Bao H; Huang X; Liu Z; Zhang W; Li F
Arch Gynecol Obstet; 2017 Feb; 295(2):407-414. PubMed ID: 27858152
[TBL] [Abstract][Full Text] [Related]
32. Basal progesterone level as the main determinant of progesterone elevation on the day of hCG triggering in controlled ovarian stimulation cycles.
Papaleo E; Corti L; Vanni VS; Pagliardini L; Ottolina J; De Michele F; La Marca A; Viganò P; Candiani M
Arch Gynecol Obstet; 2014 Jul; 290(1):169-76. PubMed ID: 24549270
[TBL] [Abstract][Full Text] [Related]
33. Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles.
Seow KM; Lin YH; Huang LW; Hsieh BC; Huang SC; Chen CY; Chen PH; Tzeng CR; Hwang JL
Gynecol Endocrinol; 2007 Jun; 23(6):338-42. PubMed ID: 17616858
[TBL] [Abstract][Full Text] [Related]
34. Value of the serum estradiol level on the day of human chorionic gonadotropin injection and on the day after in predicting the outcome in natural in vitro fertilization/intracytoplasmic sperm injection cycles.
Reljic M; Vlaisavljevic V; Gavric V; Kovacic B; Cizek-Sajko M
Fertil Steril; 2001 Mar; 75(3):539-43. PubMed ID: 11239538
[TBL] [Abstract][Full Text] [Related]
35. In vitro fertilization outcome following embryo transfer with or without preinstillation of human chorionic gonadotropin into the uterine cavity: a randomized controlled trial.
Aaleyasin A; Aghahosseini M; Rashidi M; Safdarian L; Sarvi F; Najmi Z; Mobasseri A; Amoozgar B
Gynecol Obstet Invest; 2015; 79(3):201-5. PubMed ID: 25531413
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of Ding-Kun-Dan for female infertility patients with predicted poor ovarian response undergoing in vitro fertilization/intracytoplasmic sperm injection: study protocol for a randomized controlled trial.
Ma S; Ma R; Xia T; Afnan M; Song X; Xu F; Hao G; Zhu F; Han J; Zhao Z
Trials; 2018 Feb; 19(1):124. PubMed ID: 29458401
[TBL] [Abstract][Full Text] [Related]
37. Plasmatic estradiol concentration in the mid-luteal phase is a good prognostic factor for clinical and ongoing pregnancies, during stimulated cycles of in vitro fertilization.
Florêncio RS; Meira MSB; Cunha MVD; Camarço MNCR; Castro EC; Finotti MCCF; Oliveira VA
JBRA Assist Reprod; 2018 Mar; 22(1):8-14. PubMed ID: 29338136
[TBL] [Abstract][Full Text] [Related]
38. Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages.
Huang Y; Wang EY; Du QY; Xiong YJ; Guo XY; Yu YP; Sun YP
Reprod Biol Endocrinol; 2015 Aug; 13():82. PubMed ID: 26238449
[TBL] [Abstract][Full Text] [Related]
39. Increased progesterone/estradiol ratio on the day of HCG administration adversely affects success of in vitro fertilization-embryo transfer in patients stimulated with gonadotropin-releasing hormone agonist and recombinant follicle-stimulating hormone.
Ou YC; Lan KC; Chang SY; Kung FT; Huang FJ
Taiwan J Obstet Gynecol; 2008 Jun; 47(2):168-74. PubMed ID: 18603501
[TBL] [Abstract][Full Text] [Related]
40. Prolonging oocyte in vitro culture and handling time does not compensate for a shorter interval from human chorionic gonadotropin administration to oocyte pickup.
Garor R; Shufaro Y; Kotler N; Shefer D; Krasilnikov N; Ben-Haroush A; Pinkas H; Fisch B; Sapir O
Fertil Steril; 2015 Jan; 103(1):72-5. PubMed ID: 25439844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
